AI assistant
Sending…
AtriCure, Inc. — Director's Dealing 2014
Jan 3, 2014
31802_dirs_2014-01-03_c1ef2099-1753-4c00-acd3-c22741681291.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2013-12-31
Reporting Person: Wade M. Andrew (VP and Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-12-31 | Common Stock | A | 656 | $8.09 | Acquired | 22840 | Direct |
Footnotes
F1: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2013.
F2: Closing price on December 31, 2013 was $18.68.
More from AtriCure, Inc.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 6
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3